FDA
approval
· 2018-02-26
FDA Approved: ADVIL ALLERGY AND CONGESTION RELIEF — Supplemental Application (Haleon US Holdings LLC)
Summary
FDA approves a supplemental application to market ADVIL ALLERGY AND CONGESTION RELIEF, a fixed-dose combination product containing chlorpheniramine maleate, ibu…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ADVIL ALLERGY AND CONGESTION RELIEF (CHLORPHENIRAMINE MALEATE, IBUPROFEN, AND PHENYLEPHRINE HYDROCHLORIDE)